APTO - Aptose Biosciences Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
8.39
+0.13 (+1.57%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close8.26
Open8.54
Bid8.37 x 1400
Ask8.70 x 800
Day's Range8.17 - 8.91
52 Week Range1.57 - 8.91
Volume1,174,158
Avg. Volume1,348,495
Market Cap638.528M
Beta (5Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Steven Cohen Renews His Interest in Verastem
    GuruFocus.com

    Steven Cohen Renews His Interest in Verastem

    Guru invests in restructuring cancer drug developer Continue reading...

  • Top Ranked Momentum Stocks to Buy for January 29th
    Zacks

    Top Ranked Momentum Stocks to Buy for January 29th

    Top Ranked Momentum Stocks to Buy for January 29th

  • 5 'Strong Buy' Biotech Stocks to Buy for 2020
    Kiplinger

    5 'Strong Buy' Biotech Stocks to Buy for 2020

    Investors seeking out high growth for their portfolios will often turn to biotech stocks. The biotechnology industry, which has become densely populated as our understanding of living systems and organisms continues to expand, has earned a reputation on Wall Street for its explosive potential ... and high volatility.In contrast to companies in other sectors, the gains and losses in even the best biotech stocks hinge less on earnings results, and more on a few key indicators such as trial-data readouts or verdicts from regulatory agencies. Product approvals unlock vital revenues, so a single positive update can function as a catalyst that propels shares to new highs.Of course, there's a reason risk-averse investors shy away from these stocks: The opposite also holds true.Wall Street pros rightly advise a cautious approach when evaluating the biotechnology industries. We find that monitoring the analyst community can be helpful on a couple fronts: For one, we can see where the pros are putting their faith. Also, analysts can provide much-needed insight into many stocks that get little media coverage, and whose progress can be difficult to gauge unless you're a medical expert.We used TipRanks' Stock Screener tool to comb through hundreds of biotechnology stocks to identify promising picks - ones that have received enough lopsided support from analysts that they earn TipRanks' top Strong Buy consensus rating. Here, we have found five top biotech stocks with overwhelmingly bullish sentiment from the analyst community, and price-growth projections of between 28% and 82%. SEE ALSO: 8 Stock Picks Getting Hit by Coronavirus Fears

  • Is the Options Market Predicting a Spike in Aptose (APTO) Stock?
    Zacks

    Is the Options Market Predicting a Spike in Aptose (APTO) Stock?

    Investors need to pay close attention to Aptose (APTO) stock based on the movements in the options market lately.

  • Hedge Funds Have Never Been This Bullish On Aptose Biosciences Inc (APTO)
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On Aptose Biosciences Inc (APTO)

    We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]

  • Benzinga

    The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO

    The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 16.) Acceleron Pharma Inc (NASDAQ: XLRN ) Amarin ...

  • Is Aptose Biosciences (TSE:APS) In A Good Position To Deliver On Growth Plans?
    Simply Wall St.

    Is Aptose Biosciences (TSE:APS) In A Good Position To Deliver On Growth Plans?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

  • The Zacks Analyst Blog Highlights: Middlesex Water, Howard Hughes, Ubiquiti, Aptose and Aytu
    Zacks

    The Zacks Analyst Blog Highlights: Middlesex Water, Howard Hughes, Ubiquiti, Aptose and Aytu

    The Zacks Analyst Blog Highlights: Middlesex Water, Howard Hughes, Ubiquiti, Aptose and Aytu

  • Bond Yields Plunge Globally on Slowdown Fears: 5 Safe Picks
    Zacks

    Bond Yields Plunge Globally on Slowdown Fears: 5 Safe Picks

    A growing number of central banks are giving signals for pursuing easy monetary policy in order to raise inflation and generate economic growth.

  • Associated Press

    Aptose Biosciences: 1Q Earnings Snapshot

    The Toronto-based company said it had a loss of 14 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss ...

  • Associated Press

    Aptose Biosciences: 4Q Earnings Snapshot

    On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 17 cents. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...

  • Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings?
    Zacks

    Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings?

    Bio-Rad (BIO) apprehends a year-over-year decline in revenues within Life Sciences segment due to difficult comparison.

  • Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?
    Zacks

    Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?

    An increased reimbursement of approximately $1 million has boosted Amedisys' (AMED) Hospice business.